
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Leukemia - Acute
AML not otherwise categorized
Acute basophilic leukemia
Reviewer: Daniela Mihova, M.D. (see Reviewers page)
Revised: 1 February 2013, last major update September 2012
Copyright: (c) 2001-2013, PathologyOutlines.com, Inc.
General
=========================================================================
● Rare (< 1% of AML); tumor cells have basophilic differentiation
● Associated with marrow failure, circulating blasts, skin involvement, organomegaly, hyperhistaminemia symptoms and lytic lesions
● Diagnosis: may require EM (Am J Clin Pathol 1991;96:160)
● Enzyme cytochemistry: myeloperoxidase+ by EM but negative by light microscopy; acid phosphatase+; variable PAS+ in blocks and lakes; Sudan Black B-, non-specific esterase-
● Poor prognosis
Case reports
=========================================================================
● 18 year old man with 11q23 gene rearrangement (Indian J Pathol Microbiol 2007;50:443)
● 72 year old man with monosomy 7 as only abnormality (Cancer Genet Cytogenet 2007;172:168)
● Anaphylactoid reaction after chemotherapy and disseminated intravascular coagulation with massive pulmonary hemorrhage (Cancer 1995;75:110)
Treatment
=========================================================================
● Imatinib if bcr-abl present (Ann Biol Clin (Paris) 2006;64:361)
Micro description
=========================================================================
● Hypercellular marrow composed of medium sized blasts with high N/C ratio, moderate basophilic cytoplasm with variable number of coarse basophilic granules and cytoplasmic vacuoles
● Nucleus is round, oval or bilobed with 1-3 prominent nucleoli
● Occasional immature basophils; dysplastic erythroid features
Micro images
=========================================================================
Basophilic leukemia
Peripheral blood:
Immature basophilic precursors
Bone marrow smears:
Most blasts lack differentiation, but one blast has coarse azurophilic granules
Bone marrow biopsy:
Blasts and immature basophils with variable nuclear size and nucleoli; also plasma cells, endothelial cells and hemosiderophages
Stains:
Maturing basophils have metachromatic granules with toluidine blue stain
Positive stains
=========================================================================
● CD11b, CD13, CD33, CD34, CD123, CD203c (Eur J Clin Invest 2001;31:894)
● Toluidine blue (metachromatic granules), HLA-DR; variable CD9, membranous CD22 and TdT
Negative stains
=========================================================================
● Myeloperoxidase by light microscopy
● CD117-, tryptase- and CD25- distinguish from mast cell leukemia
Molecular description
=========================================================================
● No specific findings; cases with t(6;9)(p23;q34) and with BCR-ABL1 are excluded
Electron microscopy description
=========================================================================
● Coexistance of basophilic granules and immature mast cell granules
Electron microscopy images
=========================================================================
Granules contain amorphous speckled substance, one granule has a myelin figure
Differential diagnosis
=========================================================================
● AML-M0 - EM shows no basophilic granules
● AML-M2 subtypes with basophilia: see Am J Hematol 2004;76:134
● Acute eosinophilic leukemia
● ALL with coarse granules
● CML in blast crisis
● Mast cell leukemia
End of Leukemia - Acute > AML not otherwise categorized > Acute basophilic leukemia
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).